MedPath

Effectiveness of Artificial Saliva in improving dry mouth and quality of life among the elderly

Phase 2
Conditions
Health Condition 1: K110- Atrophy of salivary gland
Registration Number
CTRI/2021/01/030436
Lead Sponsor
ot applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adults aged >=60 years, who are under at least 2 prescription medications for a year or more and unstimulated salivary flow rate <= 0.25 ml/min

Exclusion Criteria

Patients with a history of Sjogrenâ??s syndrome, Salivary gland infection, Irradiated Head and neck cancer patients,

History of total or partial removal of Salivary glands,

Participant who is not willing to sign the informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
XerostomiaTimepoint: 2 months after intervention
Secondary Outcome Measures
NameTimeMethod
oral health related quality of lifeTimepoint: 2 months after intervention
© Copyright 2025. All Rights Reserved by MedPath